TORONTO, July 6, 2020 – Reformulary Group, a Canadian healthcare company, today announced that it has entered into a non-exclusive partnership with VIVO Cannabis Inc. to advance patient outcomes via Reformulary’s Cannabis Standard™ platform.
VIVO has agreed to provide clinical support, through the Company’s Harvest Medicine clinics, to patients who access Cannabis Standard. Cannabis Standard is an ecosystem of expert recommendations, patient-powered tools, and independent information to help Canadians and healthcare professionals make smarter, more informed decisions about choosing medical cannabis. The Cannabis Standard website is set to be relaunched in mid-July.
“Cannabis Standard applies the same formula that we’ve used so successfully on the prescription medication side. We gathered a panel of independent medical experts, conducted a comprehensive review all of the available evidence globally, and created user-friendly tools to help Canadians navigate the medical cannabis space,” said Helen Stevenson, Reformulary Group founder and CEO. “At its core, Cannabis Standard is about helping patients benefit from and contribute to the growing base of medical cannabis research, and we look forward to working closely with the team at VIVO to advance patient outcomes.”
More information will be released in the coming days and weeks in relation to this partnership, and how Cannabis Standard patients can benefit from Harvest Medicine’s clinical support services.
About Reformulary Group
Founded in 2011, Reformulary Group is an expert-led healthcare company focused on helping Canadians make sense of medicine (prescription drugs and medical cannabis). The company’s proprietary drug list, the Reformulary®, and award-winning DrugFinder™ digital tool provide Canadians with valuable comparative drug information, reviewed and vetted by an independent committee of doctors and pharmacists from across Canada. Reformulary Group built Cannabis Standard™, a discovery tool to guide medical cannabis use. Cannabis Standard also enables patients to track the impact of medical cannabis on their quality of life using a survey tool recognized by healthcare professionals worldwide. For more information visit www.reformulary.com.
About VIVO Cannabis™
VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms™, Beacon Medical™, Fireside™, Fireside-X™, Lumina™ and Canadian Bud Collection™. The Company is expanding its production capabilities and distribution network. Harvest Medicine™, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The Company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information visit: www.vivocannabis.com.